In this edition, we feature an insightful article by Kim Margolin, M.D., FACP, FASCO, discussing Tumor-Infiltrating Lymphocyte (TIL) Therapy for Advanced Melanoma. We also celebrate the 20th anniversary of our Dallas Steps Against Melanoma walk and offer an exclusive interview with Dr. Allison Betof Warner, MD, PhD, on the significance of the FDA's approval of TIL Therapy for patients with Advanced Melanoma.
